EDITOR
	Neil Love, MD Medical Oncologist Editor, Breast Cancer Update for Nurses Research To Practice Miami, Florida
FACULTY AFFILIATIONS
	Howard A Burris III, MD CMO, Director, Drug Development Sarah Cannon Research Institute Nashville, Tennessee		Frances M Palmieri, RN, MSN, OCN Clinical Nurse Specialist Manager, Breast Clinic and Breast Cancer Program Mayo Clinic Jacksonville, Florida
	Charles E Geyer Jr, MD Director of Medical Affairs National Surgical Adjuvant Breast and Bowel Project Vice-Chair, Department of Human Oncology Allegheny General Hospital Pittsburgh, Pennsylvania		Edith A Perez, MD Professor of Medicine Director, Cancer Clinical Study Unit Director, Breast Cancer Program Division of Hematology and Oncology Mayo Clinic Jacksonville, Florida
	John Mackey, MD Medical Oncologist Cross Cancer Institute Professor, Medical and Experimental Oncology University of Alberta Chair of Research, Northern Alberta Breast Cancer Program Executive Director Cancer International Research Group Edmonton, Canada

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CNE activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the Research To Practice scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY — Dr Geyer — No real or apparent conflicts of interest to disclose. The following faculty (and their spouses/ partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Burris — Consulting Fees: Celgene Corporation, Keryx Biopharmaceuticals Inc, Novartis Pharmaceuticals Corporation; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Sanofi-Aventis. Dr Mackey — Honoraria: Amgen Inc, AstraZeneca Pharmaceuticals LP, Roche Laboratories Inc, Sanofi-Aventis. Ms Palmieri — Consulting Fees: Bristol-Myers Squibb Company, Roche Laboratories Inc; Speakers Bureau: Abraxis BioScience, Genentech BioOncology. Dr Perez — Contracted Research: Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Sanofi-Aventis.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

---

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

Table of Contents

Top of Page